Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Eksperimental'Naia I Klinicheskaia Farmakologiia|February 1, 2012
[Comparative characteristics of antioxidant properties of hypoglycemic agents diabenol and gliclazide]A A Spasov, V A Kosolapov, N I ChepliaevaBiomeditsinskaia Khimiia|August 18, 2005
[Study of antiradical activity of new compounds by chemiluminescence]V A Kosolapov, A A Spasov, V A AnisimovaPatologicheskaia Fiziologiia I Eksperimental'Naia Terapiia|January 18, 2006
[Modelling of intrauterine hypoxia]A A Spasov, I A Tregubova, V A KosolapovEksperimental'Naia I Klinicheskaia Farmakologiia|May 16, 2009
[Antioxidant and membranoprotective properties of trolox]E V Tibir'kova, V A Kosolapov, A A SpasovUspekhi Fiziologicheskikh Nauk|May 10, 2012
[Antioxidants: current situation and perspectives]I A Tregubova, V A Kosolapov, A A SpasovBulletin of Experimental Biology and Medicine|February 15, 2001
Dynamics of the recovery period in rats exposed to global cerebral ischemiaV V Drozd, V A Kosolapov, O V Ostrovskii, et al.Bulletin of Experimental Biology and Medicine|October 22, 2013
Antioxidant properties of pyrrolobenzimidazole derivative RU-792: experimental studyV A Kosolapov, L V Eltsova, A A Spasov, et al.Bulletin of Experimental Biology and Medicine|September 26, 2017
Effect of GRP119 Receptor Agonist, Compound MBX-2982, on Activity of Human GlucokinaseA A Spasov, V A Kosolapov, D A Babkov, et al.Bulletin of Experimental Biology and Medicine|November 30, 2013
Antithrombogenic activity of antioxidant compoundsA A Spasov, A F Kucheryavenko, V A Kosolapov, et al.Bulletin of Experimental Biology and Medicine|July 28, 2015
Effect of Pyrrolobenzimidazole Derivative RU-792 on Experimental Brain IschemiaV A Kosolapov, D V Sorotskii, A A Spasov, et al.Pageof 2